We are live on
!
Find out more
CAS
CTC Alternative Strategies Portfolio holdings
AUM
$44M
1-Year Est. Return
43.15%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+43.15%
3 Year Est. Return
+76.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
–
Cap. Flow
+$179M
Cap. Flow
% of AUM
48.32%
Top 10 Holdings %
Top 10 Hldgs %
78.73%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$58.3M |
| 2 |
Zoetis
ZTS
|
+$17.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.93M |
| 4 |
ExxonMobil
XOM
|
+$3.94M |
| 5 |
PNC.WS
PNC Financial Services Group Inc
PNC.WS
|
+$3.13M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.15% |
| 2 | Energy | 3.05% |
| 3 | Industrials | 2.5% |
| 4 | Financials | 2.35% |
| 5 | Communication Services | 2.12% |
Similar funds
ICCON
CG
VAM
SM
GC
VEPM
PCM
TA
CTC Alternative Strategies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for CTC Alternative Strategies, which disclosed 204 positions worth $371M. Its ten largest holdings account for 79% of the portfolio.
Its largest position is Pfizer: 2,109,158 shares worth $56.1M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Energy and Industrials.
- CTC Alternative Strategies's largest Q2 2013 buy was Pfizer: 2,109,158 shares worth $56.1M.
- CTC Alternative Strategies's ten largest holdings make up 79% of its $371M portfolio in Q2 2013.
- CTC Alternative Strategies disclosed 204 positions in Q2 2013, its first 13F filing on record.
Based on CTC Alternative Strategies's 13F filing for Q2 2013, filed 15 Aug 2013.